Alfresa Holdings Corporation has a total of 434 patents globally, out of which 243 have been granted. Of these 434 patents, more than 36% patents are active. Japan is where Alfresa Holdings Corporation has filed the maximum number of patents, followed by USA and Europe and it also seems reasonable as the biggest market for Alfresa Holdings Corporation is Japan. Parallelly, Japan seems to be the main focused R&D center and is also the origin country of Alfresa Holdings Corporation.
Alfresa Holdings Corporation was founded in 2003, Alfresa Holdings operates through three segments that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. The Self-Medication Products Wholesaling segment sells general over-the-counter drugs; and the Manufacturing segment manufactures and markets products in the fields of pharmaceuticals, diagnostics and medical equipment. As of January 2022, Alfresa Holdings Corporation has a market cap of $330.59 Billion.
Do read about some of the most popular patents of Alfresa Holdings Corporation which have been covered by us in this article and also you can find Alfresa Holdings Corporation patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over the Alfresa Holdings Corporation patent portfolio.
How many patents does Alfresa Holdings Corporation have?
Alfresa Holdings Corporation has a total of 434 patents globally. These patents belong to 240 unique patent families. Out of 434 patents, 158 patents are active.
How many Alfresa Holdings Corporation patents are Alive/Dead?
Worldwide Patents
How Many Patents did Alfresa Holdings Corporation File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Alfresa Applications Filed | Alfresa Patents Granted |
| 2011 | 3 | 24 |
| 2012 | 7 | 27 |
| 2013 | 11 | 11 |
| 2014 | 18 | 14 |
| 2015 | 20 | 9 |
| 2016 | 8 | 20 |
| 2017 | 19 | 17 |
| 2018 | 17 | 15 |
| 2019 | 8 | 18 |
| 2020 | 3 | 26 |
| 2021 | 4 | 9 |
How Many Patents did Alfresa Holdings Corporation File in Different Countries?
Countries in which Alfresa Holdings Corporation Filed Patents
| Country | Patents |
| Japan | 201 |
| Europe | 37 |
| United States Of America | 36 |
| Germany | 20 |
| China | 19 |
| Korea (South) | 17 |
| Austria | 9 |
| Spain | 8 |
| Canada | 5 |
| Taiwan | 4 |
| India | 4 |
| Hong Kong (S.A.R.) | 4 |
| Australia | 4 |
| Viet Nam | 3 |
| Singapore | 2 |
| Italy | 2 |
| Portugal | 1 |
| Denmark | 1 |
| United Kingdom | 1 |
| Indonesia | 1 |
Where are Research Centers of Alfresa Holdings Corporation Patents Located?
10 Best Alfresa Holdings Corporation Patents
JP2001087272A is the most popular patent in the Alfresa Holdings Corporation portfolio. It has received 1016 citations so far from companies like Ethicon Inc, Covidien and Applied Medical Resources Corporation.
Below is the list of 10 most cited patents of Alfresa Holdings Corporation:
| Publication Number | Citation Count |
| JP2001087272A | 1016 |
| US6451014B1 | 84 |
| WO2000021448A1 | 44 |
| JP2005283250A | 34 |
| WO2001052751A1 | 28 |
| US8029513B2 | 24 |
| WO2000032808A1 | 24 |
| US6686172B2 | 23 |
| WO2011055670A1 | 20 |
| WO2001058629A1 | 20 |
What Percentage of Alfresa Holdings Corporation US Patent Applications were Granted?
Alfresa Holdings Corporation (Excluding its subsidiaries) has filed 25 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 15 have been granted leading to a grant rate of 65.22%.
Below are the key stats of Alfresa Holdings Corporation patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Alfresa Holdings Corporation?
| Law Firm | Total Applications | Success Rate |
| The Webb Law Firm | 9 | 44.44% |
| Millen White Zelano & Branigan | 5 | 60.00% |
| Hamre Schumann Mueller & Larson | 2 | 0.00% |
| Hespos & Porco | 2 | 100.00% |
| Wenderoth Lind & Ponack | 2 | 100.00% |
| Kilyk & Bowersox | 1 | 100.00% |
| Nixon & Vanderhye | 1 | 100.00% |
| Orrick Herrington & Sutcliffe | 1 | 100.00% |
Through the discovery, manufacture, and marketing of pharmaceuticals, diagnostic reagents, medical equipment, and health-related items, Alfresa Group aspires to contribute to a global culture of health. Alfresa Group is a high-end product R&D and production company that caters to a wide range of medical demands. They also want to improve their sales, production, and research and development capacities by forming collaborations with companies that have sophisticated technology and products. Alfresa Group will continue to do R&D and seek to maintain a constant supply of high-quality, high-value-added products, keeping its focus on dependable, safe, and honest manufacturing. We will work to build a structure that can respond to a wide range of medical needs.
EXCLUSIVE INSIGHTS COMING SOON!
What are Alfresa Holdings Corporation’s key innovation segments?
What Technologies are Covered by Alfresa Holdings Corporation?
The chart below distributes patents filed by Alfresa Holdings Corporation in different countries on the basis of the technology protected in patents. It also represents the markets where Alfresa Holdings Corporation thinks it’s important to protect particular technology inventions.
R&D Focus: How Alfresa Holdings Corporation search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Alfresa Holdings Corporation?
